DiaMedica Therapeutics Inc DMAC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
3.00quote price arrow up+0.37 (+14.07%)
Volume
102,642
52 week range
1.58 - 4.75
Loading...
  • Open2.65
  • Day High3.05
  • Day Low2.65
  • Prev Close2.63
  • 52 Week High4.75
  • 52 Week High Date06/26/23
  • 52 Week Low1.58
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap113.874M
  • Shares Out37.96M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • YTD % Change5.63

KEY STATS

  • Open2.65
  • Day High3.05
  • Day Low2.65
  • Prev Close2.63
  • 52 Week High4.75
  • 52 Week High Date06/26/23
  • 52 Week Low1.58
  • 52 Week Low Date05/12/23
  • Market Cap113.874M
  • Shares Out37.96M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • YTD % Change5.63

RATIOS/PROFITABILITY

  • EPS (TTM)-0.62
  • P/E (TTM)-4.86
  • Fwd P/E (NTM)-4.24
  • EBITDA (TTM)-21.237M
  • ROE (TTM)-46.77%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,448.65%
  • Debt To Equity (MRQ)0.01%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On DiaMedica Therapeutics Inc

 

Profile

MORE
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in patients. KLK1 is an established therapeutic modality in Asia, with human urinary KLK1...
Richard Pilnik
Independent Chairman of the Board
Rick Pauls
President, Chief Executive Officer, Director
Scott Kellen
Chief Financial Officer, Company Secretary
Ambarish Shah Ph.D.
Chief Technology Officer
Address
301 CARLSON PARKWAY, SUITE 210
Minneapolis, MN
55305
United States

Top Peers

SYMBOLLASTCHG%CHG
SVA
Sinovac Biotech Ltd
0.00-6.47-100.00%
EPRX
Eupraxia Pharmaceuticals Inc
2.88+0.10+3.78%
ARCH
Arch Resources Inc
161.43+3.04+1.92%
ONC
CRDL
Cardiol Therapeutics Inc
1.99+0.01+0.51%